FULCRUM THERAPEUTICS, INC. (FULC) Return on equity 2020–2025
FULCRUM THERAPEUTICS, INC. (FULC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-21.5%FY2025 · since FY2020: -74.4% → -21.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -21.5% | -17.5 pp |
| FY2024 | -4.0% | +37.4 pp |
| FY2023 | -41.4% | +13.8 pp |
| FY2022 | -55.2% | -17.0 pp |
| FY2021 | -38.2% | +36.2 pp |
| FY2020 | -74.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice